Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018 - MarketsandMarkets

Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018 - MarketsandMarkets
Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
Published Mar 26, 2013
452 pages — Published Mar 26, 2013
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:

The global POC diagnostics market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil. Factors such as rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, technological advancements, and decreasing number of technicians in the central labs are propelling the growth of the POC diagnostics market. However, factors such as lack of alignment with definitive central lab methods, reluctance to change existing treatment practices and the recall of leading glucose monitoring devices are restraining the growth of this market.

In this report, the global POC diagnostics market has been segmented on the basis of category (infectious diseases testing kits, glucose monitoring kits, cardiac markers, pregnancy and fertility testing kits, and others) and end users (patient professional monitoring kits and patient self-monitoring kits). The glucose monitoring kits market held the largest share-53.7%-of the global POC diagnostics market in 2013, followed by the infectious diseases testing kits market. Factors such as rising global prevalence of diabetes, technological advancements in self-monitoring of blood glucose, and the growing patient awareness toward POC testing are stimulating the growth of the glucose monitoring kits market.

The fastest-growing segment-cardiac-markers market-is projected to grow at a CAGR of 15.3% from 2013 to 2018. This growth is mainly attributed to the increasing number of cardiac patients and the demand of immediate diagnosis of the diseases. Major players such as Roche (Switzerland), Abbott Laboratories, Inc. (U.S.), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.), and Alere Inc. (U.S.) are adopting several growth strategies such as new product launches, partnerships, agreements, collaborations, joint ventures, and mergers and acquisition in order to keep pace with the evolving industry trends.

Geographically, North America commands the largest share of the global POC diagnostics market in 2013, followed by Asia-Pacific. A number of factors such as increase in waiver of CLIA for certain point of care diagnostic tests, fostering FDA approvals for various immunoassay techniques, easy access to POC tests through diagnostic service providers, and presence of major leading companies are driving the growth of the POC diagnostics market in North America. However, the economic slowdown and unfavorable reimbursement scenario for tests due to government budget constraints the growth of the POC diagnostics market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years. Factors such as huge patient population base, large number of R&D activities, and growing focus of both international and domestic players on the Asia-Pacific POC diagnostics market are propelling the growth of the dialysis market in the Asia-Pacific region.

The global POC diagnostics market is highly competitive with a large number of global as well as local market players. As of 2012, the global POC diagnostics market excluding the blood glucose monitoring kits market was dominated by Roche (Switzerland), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.), which together accounted for ~72% of the market. New product launches and partnerships/agreements/collaborations/joint ventures are the major strategies adopted by most market players to achieve growth in the POC diagnostics market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry analysis (PEST analysis and Porter's five force model), market share analysis of top players, value chain analysis, supply chain analysis, and company profiles, which together com

  
Source:
Document ID
BT 2328
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
Table of Contents

1Introduction (Page No. - 25)
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Market Share Estimation
1.6.4 Key Data Points From Secondary Sources
1.6.5 Key Data Points From Primary Sources
1.6.6 Assumptions

2 Executive Summary (Page No. - 37)

3 Premium Insights (Page No. - 42)
3.1 Product Growth Matrix
3.2 Life Cycle Analysis, By Geography
3.3 Market Chasm Analysis

4 Market Overview (Page No. - 47)
4.1 Introduction
4.2 Evolution
4.3 Market Segmentation
4.3.1 Point of Care Diagnostics Market By Product
4.3.2 Point of Care Diagnostics Market By Prescription Mode
4.3.3 Point of Care Diagnostics Market By End User
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Huge prevalence of infectious diseases in developing countries
4.4.1.2 Increasing incidences of lifestyle diseases (cardiac diseases and diabetes)
4.4.1.3 Rising usage of home-based POC devices is improving patient compliance
4.4.1.4 Private investments and venture funding to support development of new products
4.4.1.5 Growing government support to magnify the adoption of POC devices
4.4.1.6 Expansion of therapeutic horizon
4.4.1.7 Fostering approval of novel immunoassay techniques
4.4.1.8 Technological advancements
4.4.1.9 Large number of awareness campaigns/ conferences in developing countries
4.4.1.10 Decreasing number of technicians available in central labs
4.4.2 Restraints
4.4.2.1 Lack of alignment with definitive central lab methods
4.4.2.2 Disadvantages of POC testing over central lab methods
4.4.2.3 Recall of leading glucose monitoring devices
4.4.2.4 Reluctance to change the existing treatment practices
4.4.3 Oppurtunities
4.4.3.1 Emerging markets(India, China, and Brazil)
4.4.3.2 Healthcare decentralization
4.4.3.3 Miniaturization of POC testing devices
4.4.4 Challenges
4.4.4.1 Growing price-cutting measures
4.4.4.2 Stringent and time-consuming regulatory policies
4.4.5 Burning Issues
4.4.5.1 Unfavorable reimbursement scenario in many countries
4.4.5.2 High cost of POC devices
4.4.6 Winning Imperatives
4.4.6.1 Strategy of geographic expansion in emerging markets
4.4.6.2 Strategy of development of low-cost POC devices
4.4.6.3 Strategy of development of multi-assay POC devices

5 Industry Trends (Page No. - 68)
5.1 Introduction
5.2 Value Chain Analysis
5.3 Supply Chain Analysis
5.3.1 Key Influencers:
5.4 Industry Trends
5.4.1 Standardization Of Poc Testing Devices
5.4.2 Acquisition Of Small Players
5.4.3 Growing Focus On Microfluidics-Based Poc Devices
5.4.3.1 Microfluidic technology based lab-on-a-chip devices will bring laboratory testing to patient's finger tips
5.5 Pricing And Cost Analysis
5.6 Porter's Five Forces Analysis
5.6.1 Threat From New Entrants
5.6.2 Threat From Substitutes
5.6.3 Bargaining Power Of Suppliers
5.6.4 Bargaining Power Of Buyers
5.6.

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018" Mar 26, 2013. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/Point-Of-Care-Diagnostic-Market-by-Products-Glucose-Monitoring-Infectious-Diseases-Testing-Kits-Cardiac-Tumor-Markers-by-End-Users-Self-Professional-Monitoring-Over-the-Counter-Prescription-Based-Global-Forecast-to-2018-2144-613>
  
APA:
MarketsandMarkets. (2013). Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018 Mar 26, 2013. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/Point-Of-Care-Diagnostic-Market-by-Products-Glucose-Monitoring-Infectious-Diseases-Testing-Kits-Cardiac-Tumor-Markers-by-End-Users-Self-Professional-Monitoring-Over-the-Counter-Prescription-Based-Global-Forecast-to-2018-2144-613>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.